✨ Free AI Report
Co-Diagnostics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Co-Diagnostics, Inc.
Research Preview

Co-Diagnostics, Inc.: Business Overview, Financials & Competitive Analysis

Co-Diagnostics, Inc. is a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests. The company offers the Co-Dx PCR platform for polymerase chain reaction testi...

Analyst-debate audio for Co-Diagnostics, Inc.

AskCyborg analysts argue the bull and bear cases for Co-Diagnostics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Co-Diagnostics, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
3/ 10Challenged

Cyborg Score thesis

Early-stage molecular diagnostics platform with promising point-of-care PCR technology but facing significant commercialization...

Read the full analyst-debate transcript →
Industry Molecular Diagnostics
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 8, 2026
AI-Verified Research
30+ Page Report

Get the Latest Co-Diagnostics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Co-Diagnostics, Inc. Overview

Pro stress-test →

Co-Diagnostics, Inc. is a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests. The company offers the Co-Dx PCR platform for polymerase chain reaction testing and provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus.

Strategic Profile

Pro stress-test →

The company is in early commercialization phase with Q1 2026 revenue of $0.15 million, up from $0.05 million a year earlier, but remains unprofitable. As of March 31, 2026, cash totaled $8.2 million, down from $11.9 million at year-end, as the company invests in R&D and expands regulatory certifications globally.

Competitive Landscape

Pro stress-test →

Co-Diagnostics competes in the molecular diagnostics space against larger, established players in PCR testing and point-of-care diagnostics. The company's proprietary platform and focus on infectious disease detection position it in a niche market segment, but it faces competition from major diagnostic companies with greater resources and commercial scale.

Industry Context

Co-Diagnostics, Inc. operates in Molecular Diagnostics.

Key facts

Headquarters: Salt Lake City, US · Revenue: $0.146M (Q1 2026) · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Co-Diagnostics, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Co-Diagnostics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Cepheid GeneXpertLeading point-of-care molecular diagnostics platform→Qiagen QIAsymphonyAutomated molecular diagnostic testing platform→Abbott RealTime PCRPCR-based infectious disease diagnostics→

Compare Co-Diagnostics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Co-Diagnostics, Inc. operates in Molecular Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse Molecular Diagnostics research →
NEW · MCP server

Ask your AI assistant about Co-Diagnostics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Co-Diagnostics, Inc. and its top competitor on Cyborg Score”
“What did Co-Diagnostics, Inc. do this quarter?”
“Is Co-Diagnostics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Co-Diagnostics, Inc. do?+
Co-Diagnostics, Inc. is a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests. The company offers the Co-Dx PCR platform for polymerase chain reaction testi...
What is Co-Diagnostics, Inc.'s Cyborg Score?+
Co-Diagnostics, Inc. has a Cyborg Score of 3/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Co-Diagnostics, Inc.'s main competitors?+
Named competitors include Cepheid GeneXpert, Qiagen QIAsymphony, Abbott RealTime PCR. The full competitive landscape is in the AskCyborg report.
How can I get the full Co-Diagnostics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Co-Diagnostics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Co-Diagnostics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Rasan Information Technology Company9Aritzia Inc.9Coherent Corp.9SanDisk Corporation9Zhongji Innolight Co., Ltd.9Cintas Corporation9Lockheed Martin Corporation9ASML Holding N.V.9Broadcom Inc.8Hamilton Insurance Group, Ltd.8Agility Global8Monogram Technologies Inc.8Smartoptics Group ASA8Sidetrade SA8Schweizerische Nationalbank8Funding Circle Holdings plc8BitFuFu Inc.8COMPASS Pathways plc